Monitoring Parameters During the Immediate Postnatal Transition Period and Inflammatory Markers in the First Two Days After Birth—A Retrospective Data Analysis
Highlights
- •
- Early inflammatory markers (CRP and IT ratio) within the first 48 h after birth correlate with cerebral and systemic oxygenation during immediate postnatal transition.
- •
- Microcirculatory alterations may occur despite stable systemic hemodynamics. Inflammatory markers were associated with oxygenation disturbances, while heart rate and mean arterial blood pressure remained unaffected, suggesting subclinical microvascular dysfunction.
- •
- Cerebral oxygenation monitoring may reveal subtle vulnerabilities not captured by routine monitoring. Near-infrared spectroscopy (NIRS) detected alterations in cerebral oxygenation that were not reflected by conventional cardiovascular parameters.
- •
- The findings highlight the preventive potential of early risk stratification. Identifying neonates with early inflammatory activation may support targeted monitoring strategies to optimize oxygen delivery during this critical developmental window. These findings suggest that inflammation affects neonatal microcirculation before conventional hemodynamic changes become evident.
Abstract
1. Introduction
2. Materials and Methods
2.1. Design
2.2. Inclusion and Exclusion Criteria
2.3. Monitoring
2.4. Laboratory Analyses
2.5. Statistical Analysis
3. Results
4. Discussion
Limitations and Strengths
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Rudolph, A.M. Fetal and Neonatal Pulmonary Circulation. Am. Rev. Respir. Dis. 1977, 115, 11–18. [Google Scholar] [CrossRef] [PubMed]
- Morton, S.U.; Brodsky, D. Fetal Physiology and the Transition to Extrauterine Life. Clin. Perinatol. 2016, 43, 395–407. [Google Scholar] [CrossRef] [PubMed]
- Pichler, G.; Goeral, K.; Hammerl, M.; Perme, T.; Dempsey, E.M.; Springer, L.; Lista, G.; Szczapa, T.; Fuchs, H.; Karpinski, L.; et al. Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates during Immediate Transition after Birth (COSGOD III): Multicentre Randomised Phase 3 Clinical Trial. BMJ 2023, 380, e072313. [Google Scholar] [CrossRef] [PubMed]
- Wolfsberger, C.H.; Schwaberger, B.; Urlesberger, B.; Avian, A.; Goeral, K.; Hammerl, M.; Perme, T.; Dempsey, E.M.; Springer, L.; Lista, G.; et al. Reference Ranges for Arterial Oxygen Saturation, Heart Rate, and Cerebral Oxygen Saturation during Immediate Postnatal Transition in Neonates Born Extremely or Very Preterm. J. Pediatr. 2024, 273, 114132. [Google Scholar] [CrossRef] [PubMed]
- Gan, Y.; Ying, J.; Qiu, X.; You, S.; Zhang, T.; Ruan, T.; Zhou, R.; Ye, Y.; Yue, Y.; Zhang, L.; et al. Value of Near-Infrared Spectroscopy in Evaluating the Risk of Neonatal Necrotizing Enterocolitis: A Systematic Review and Meta-Analysis. Early Hum. Dev. 2024, 195, 106083. [Google Scholar] [CrossRef] [PubMed]
- Weidlich, K.; Kroth, J.; Nussbaum, C.; Hiedl, S.; Bauer, A.; Christ, F.; Genzel-Boroviczeny, O. Changes in Microcirculation as Early Markers for Infection in Preterm Infants—An Observational Prospective Study. Pediatr. Res. 2009, 66, 461–465. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Pichler, G.; Pocivalnik, M.; Riedl, R.; Pichler-Stachl, E.; Zotter, H.; Müller, W.; Urlesberger, B. C Reactive Protein: Impact on Peripheral Tissue Oxygenation and Perfusion in Neonates. Arch. Dis. Child.-Fetal Neonatal Ed. 2012, 97, F444–F448. [Google Scholar] [CrossRef] [PubMed]
- Binder, C.; Urlesberger, B. Leukocytes Influence Peripheral Tissue Oxygenation and Perfusion in Neonates. Signa Vitae 2013, 8, 20. [Google Scholar] [CrossRef][Green Version]
- Wolfsberger, C.H.; Bruckner, M.; Baik-Schneditz, N.; Schwaberger, B.; Mileder, L.P.; Avian, A.; Urlesberger, B.; Pichler, G. Fetal Inflammatory Response Syndrome and Cerebral Oxygenation During Immediate Postnatal Transition in Preterm Neonates. Front. Pediatr. 2020, 8, 401. [Google Scholar] [CrossRef] [PubMed]
- Bresesti, I.; Bruckner, M.; Mattersberger, C.; Baik-Schneditz, N.; Schwaberger, B.; Mileder, L.; Avian, A.; Urlesberger, B.; Pichler, G. Feasibilty of Transcutaneous pCO2 Monitoring During Immediate Transition After Birth—A Prospective Observational Study. Front. Pediatr. 2020, 8, 11. [Google Scholar] [CrossRef] [PubMed]
- Chiesa, C.; Pellegrini, G.; Panero, A.; Osborn, J.F.; Signore, F.; Assumma, M.; Pacifico, L. C-Reactive Protein, Interleukin-6, and Procalcitonin in the Immediate Postnatal Period: Influence of Illness Severity, Risk Status, Antenatal and Perinatal Complications, and Infection. Clin. Chem. 2003, 49, 60–68. [Google Scholar] [CrossRef] [PubMed]
- Roberts, D.; Dalziel, S.R. Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth. In Cochrane Database of Systematic Reviews; Roberts, D., Ed.; John Wiley & Sons, Ltd.: Chichester, UK, 2006. [Google Scholar]
- Simonsen, K.A.; Anderson-Berry, A.L.; Delair, S.F.; Davies, H.D. Early-Onset Neonatal Sepsis. Clin. Microbiol. Rev. 2014, 27, 21–47. [Google Scholar] [CrossRef] [PubMed]
- Hofer, N.; Zacharias, E.; Müller, W.; Resch, B. An Update on the Use of C-Reactive Protein in Early-Onset Neonatal Sepsis: Current Insights and New Tasks. Neonatology 2012, 102, 25–36. [Google Scholar] [CrossRef] [PubMed]
- Linderkamp, O.; Ruef, P.; Brenner, B.; Gulbins, E.; Lang, F. Passive Deformability of Mature, Immature, and Active Neutrophils in Healthy and Septicemic Neonates. Pediatr. Res. 1998, 44, 946–950. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Shane, A.L.; Sánchez, P.J.; Stoll, B.J. Neonatal Sepsis. Lancet 2017, 390, 1770–1780. [Google Scholar] [CrossRef]
- Stocker, M.; van Herk, W.; el Helou, S.; Dutta, S.; Schuerman, F.A.B.A.; van den Tooren-de Groot, R.K.; Wieringa, J.W.; Janota, J.; van der Meer-Kappelle, L.H.; Moonen, R.; et al. C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-Onset Sepsis Within 36 h: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study. Clin. Infect. Dis. 2021, 73, e383–e390. [Google Scholar] [CrossRef]


| Median | IQR | |
|---|---|---|
| Gestational age [weeks] | 34.0 | 32.0; 35.9 |
| Birth weight [g] | 1900 | 1488; 2542 |
| Apgar 1 min | 8 | 8; 9 |
| Apgar 5 min | 9 | 9; 10 |
| Apgar 10 min | 10 | 9; 10 |
| Umbilical cord artery pH | 7.32 | 7.29; 7.34 |
| Monitoring parameter 5 min after birth | ||
| SpO2 [%] | 79 | 64; 89 |
| HR [bpm] | 148 | 140; 161 |
| crSO2 [%] | 60 | 33; 75 |
| Monitoring parameters 10 min after birth | ||
| SpO2 [%] | 91 | 87; 96 |
| HR [bpm] | 148 | 141; 156 |
| crSO2 [%] | 82 | 68; 89 |
| Transcutaneous pCO2 [mmHg] | 49.0 | 44.0; 53.8 |
| Monitoring parameters 15 min after birth | ||
| SpO2 [%] | 94 | 90; 97 |
| HR [bpm] | 152 | 144; 165 |
| crSO2 [%] | 82 | 74; 92 |
| SABP [mmHg] | 60 | 56; 65 |
| DABP [mmHg] | 34 | 28; 39 |
| MABP [mmHg] | 43 | 39; 47 |
| Transcutaneous pCO2 [mmHg] | 50.5 | 41.5; 57.0 |
| Capillary blood gas analysis | ||
| Postnatal age [minutes] | 17 | 16; 19 |
| pH | 7.28 h | 7.22; 7.31 |
| pCO2 [mmHg] | 55.1 | 48.8; 62.7 |
| Haematocrit [%] | 55.2 | 51.9; 59.0 |
| Infectious variables 16–24 hours after birth | ||
| CRP [mg/L] | 0.9 | 0.6; 2.9 |
| Leukocytes [/µL] | 15,160 | 9789; 20,110 |
| IT ratio | 0.02 | 0.00; 0.05 |
| Infectious variables 24–48 h after birth | ||
| CRP [mg/L] | 1.2 | 0.6; 3.8 |
| Leukocytes [/µL] | 11,680 | 10,570; 20,238 |
| IT ratio | 0.02 | 0.00; 0.04 |
| CRP | Leukocytes | IT Ratio | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | r | p-Value | n | r | p-Value | n | r | p-Value | |
| SpO2 min 5 | 65 | −0.196 | 0.118 | 65 | −0.052 | 0.681 | 65 | −0.327 | 0.008 |
| SpO2 min 10 | 64 | −0.208 | 0.099 | 63 | −0.060 | 0.640 | 63 | −0.241 | 0.057 |
| SpO2 min 15 | 64 | −0.393 | 0.001 | 64 | 0.081 | 0.522 | 64 | −0.238 | 0.059 |
| HR min 5 | 47 | −0.177 | 0.233 | 47 | 0.154 | 0.301 | 47 | −0.083 | 0.579 |
| HR min 10 | 47 | −0.048 | 0.748 | 47 | −0.023 | 0.876 | 47 | −0.083 | 0.579 |
| HR min 15 | 48 | 0.018 | 0.901 | 48 | −0.072 | 0.626 | 48 | −0.135 | 0.361 |
| crSO2 min 5 | 57 | −0.130 | 0.337 | 57 | −0.265 | 0.046 | 57 | −0.367 | 0.005 |
| crSO2 min 10 | 60 | −0.199 | 0.127 | 60 | −0.147 | 0.262 | 60 | −0.273 | 0.035 |
| crSO2 min 15 | 65 | −0.314 | 0.011 | 65 | −0.018 | 0.885 | 65 | −0.306 | 0.013 |
| MABP min 15 | 58 | −0.053 | 0.691 | 58 | 0.030 | 0.822 | 58 | −0.038 | 0.778 |
| CRP | Leukocytes | IT Ratio | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | r | p-Value | n | r | p-Value | n | r | p-Value | |
| SpO2 min 5 | 52 | 0.117 | 0.408 | 53 | 0.030 | 0.832 | 42 | −0.077 | 0.626 |
| SpO2 min 10 | 51 | 0.108 | 0.453 | 52 | −0.056 | 0.692 | 41 | −0.104 | 0.517 |
| SpO2 min 15 | 51 | −0.136 | 0.340 | 52 | 0.069 | 0.627 | 41 | −0.204 | 0.200 |
| HR min 5 | 35 | −0.133 | 0.447 | 36 | 0.172 | 0.316 | 25 | −0.181 | 0.387 |
| HR min 10 | 36 | 0.034 | 0.846 | 36 | −0.202 | 0.231 | 25 | 0.032 | 0.352 |
| HR min 15 | 35 | −0.096 | 0.577 | 37 | 0.049 | 0.777 | 26 | −0.190 | 0.880 |
| crSO2 min 5 | 46 | 0.199 | 0.185 | 47 | −0.092 | 0.537 | 38 | −0.064 | 0.702 |
| crSO2 min 10 | 50 | 0.096 | 0.509 | 51 | −0.142 | 0.320 | 41 | −0.190 | 0.233 |
| crSO2 min 15 | 52 | −0.080 | 0.575 | 53 | −0.060 | 0.669 | 42 | −0.384 | 0.012 |
| MABP min 15 | 45 | −0.267 | 0.077 | 46 | −0.052 | 0.733 | 36 | −0.191 | 0.264 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Wolfsberger, C.H.; Hierz, A.; Holter, M.; Baik-Schneditz, N.; Suppan, E.; Schwaberger, B.; Pichler, G. Monitoring Parameters During the Immediate Postnatal Transition Period and Inflammatory Markers in the First Two Days After Birth—A Retrospective Data Analysis. Children 2026, 13, 529. https://doi.org/10.3390/children13040529
Wolfsberger CH, Hierz A, Holter M, Baik-Schneditz N, Suppan E, Schwaberger B, Pichler G. Monitoring Parameters During the Immediate Postnatal Transition Period and Inflammatory Markers in the First Two Days After Birth—A Retrospective Data Analysis. Children. 2026; 13(4):529. https://doi.org/10.3390/children13040529
Chicago/Turabian StyleWolfsberger, Christina H., Andreas Hierz, Magdalena Holter, Nariae Baik-Schneditz, Ena Suppan, Bernhard Schwaberger, and Gerhard Pichler. 2026. "Monitoring Parameters During the Immediate Postnatal Transition Period and Inflammatory Markers in the First Two Days After Birth—A Retrospective Data Analysis" Children 13, no. 4: 529. https://doi.org/10.3390/children13040529
APA StyleWolfsberger, C. H., Hierz, A., Holter, M., Baik-Schneditz, N., Suppan, E., Schwaberger, B., & Pichler, G. (2026). Monitoring Parameters During the Immediate Postnatal Transition Period and Inflammatory Markers in the First Two Days After Birth—A Retrospective Data Analysis. Children, 13(4), 529. https://doi.org/10.3390/children13040529

